Main menu

Call for Fellows

The Japanese Society of Pharmacokinetics and Safety Evaluation (JSSX) invites applications for JSSX Fellows for the academic year 2024.

 The JSSX Fellow (hereinafter referred to as “JSSX Fellow”) is an honorary member of the Japanese Society of Pharmacokinetics and Pharmacodynamics (JSSX), who is expected to continue to contribute to the society as part of its social mission to contribute to drug development and medical care through research, education and administration in the field of pharmacokinetics, and to make a significant contribution to the society. In light of the fact that the Society has members from a wide range of industries, academia, and government, and from various backgrounds, and that it advocates active international activities, the Society has newly established this award since 2008 to “honor members who have made significant achievements both in Japan and abroad, and who are expected to continue contributing to the Society” ( see Rules below ).

 We encourage all board members, former board members, and fellows to submit nominations in accordance with the following guidelines. The title of JSSX Fellow will be awarded at the 38th Annual Meeting of the Society to be held from September 15, 2024.

Open Call for Proposals

Deadline Monday, May 20, 2024, 17:00
Decision Around August 2024 To be notified in writing to the applicant
Document Submission Method Nominators are requested to submit the following documents in a single PDF file as an e-mail attachment to maf-jssx@mynavi.jp by the deadline. If you have not received a reply by May 22 (Wen.) indicating that the attached documents have been received, please contact the following address.
Inquiries should be addressed to Secretariat of the Japanese Society for Pharmacokinetics
TEL: 03-6267-4550
FAX: 03-6267-4555
E-mail: maf-jssx@mynavi.jp
Documents Documents can be downloaded from here.
For Japanese MembersFor Foreign Members

I. Submission Documents and Procedures (for Japanese Members)

1. Fellow candidates (nominees) should be nominated by a current or former director or fellow of the Society. The nominator must submit the “JSSX Fellow Nomination Form (Form F-1) and Statement of Reasons for Nomination (Form F-2)” with the names, affiliations, addresses, and contact information of the nominator and the nominee, and a letter of recommendation from a current or former director, fellow, or delegate other than the nominator. A letter of recommendation (Form F-3) from a current board member other than the nominator, an experienced board member, a fellow, or a delegate, and a brief CV of the nominee (any form, no more than 2 pages in A4 size) should be submitted to the “Fellows Selection Committee. A nominator may nominate only one candidate.

2. Letter of Reason for Nomination and Reference Data
The letter of reasons for recommendation (Form F-2) should state in writing why the nominee is suitable for the Fellowship in relation to the purpose stated in Article 1 of the “Selection Rules for Fellows of the Japanese Society of Pharmacokinetics”. For the purpose of making this statement of reasons for recommendation more persuasive, we recommend, for example, that at least one item from items A through E below be accompanied by relevant reference data. Submission of these reference data is not mandatory, but if submitted, they will be considered as reference material for the selection process.

The format and content of the reference data may be freely chosen.

A. Noteworthy Research Achievements
List up to five research achievements (original papers, reviews, or books) that deserve special mention, and briefly describe how they are outstanding achievements in pharmacokinetics and how they have contributed to the development of the field. You may also include information such as the number of citations and the journal’s impact factor, if necessary. Reprints or photocopies may be attached as reference materials.

B. Other achievements related to research and educational activities
List any other achievements such as invited lectures in Japan and abroad, patents, sponsorship of conferences, symposia, and workshops, research guidance for undergraduate and graduate students, and acquisition of research funds that deserve special mention and describe how they contribute to pharmacokinetics and pharmacodynamics.

C. Contributions to the Japanese Pharmacokinetics Society
Specifically list outstanding activities as a board member, delegate, committee member, annual meeting chair, international activities, DMPK editorial board member, DMPK article reviewer, etc., and describe how the member has contributed to the Japanese Pharmacokinetics Society.

D. Contributions to drug development, administrative reform, medical activities, etc.
Specifically list activities of particular note in drug development, administrative system reform, medical activities, etc., and describe how they have contributed to pharmacokinetics or the society.

E. Others
List any achievements not included in the above that deserve special mention.

II. Documents to be submitted and procedures (for non-Japanese applicants)

1. Fellow candidates (nominees) should be nominated by a current or former director or fellow of the Society. The nominator should submit the “JSSX Fellow Nomination Form (Form F-1e) and Statement of Reasons for Nomination (Form F-2e)” with the names, affiliations, addresses, and contact information of the nominator and the nominee, along with a letter of recommendation (Form F-1e) from a current or former director, fellow, or delegate other than the nominator. A letter of recommendation (Form F-3e) from a current board member other than the nominator, an experienced board member, a fellow, or a delegate, together with a brief biography of the nominee (no more than two pages of A4 size, any format), should be submitted to the Fellow Selection Committee. A nominator may only nominate one candidate. If the nominator submitting the letter of recommendation is a non-Japanese, the letter of recommendation (Form F-3) must be submitted by a Japanese.

2. Recommendation Documents
The letter of reasons for recommendation (Form F-2e) should state in writing why the nominee is suitable as a Fellow in relation to the purpose stated in Article 1 of the “Selection Rules for Fellows of the Japanese Society of Pharmacokinetics”. Foreign Fellows are expected to contribute to the internationalization and revitalization of the society. Therefore, the reasons for the nomination, including the nominee’s will and achievements, should be written in the nomination statement, and for the purpose of making the nomination more persuasive, the data in A below should be attached. In addition, it is recommended that the applicant state in detail his/her achievements and future expectations regarding B below, even if they are duplicated in the statement of reasons for nomination.

The format and content of A and B may be freely chosen.

A. Achievements related to academic papers, research and educational activities, etc.
A list should be made of research achievements (original papers, reviews, books), invited lectures, patents, organization of conferences, symposiums, and workshops, research guidance for undergraduate and graduate students, acquisition of research funds, and other pertinent items. Reprints or copies may be attached as reference materials.

B. Contributions to the Japanese Pharmacokinetics Society
Describe how you have contributed to the society and what kind of contributions can be expected in the future. Contributions may include, for example, JSSX membership, participation, presentations, chairing, and planning at annual meetings, symposia, and other related meetings, contributions to DMPK, and contributions as a reviewer, etc., related to the revitalization and internationalization of the society. The specific fields of research in which Fellows are expected to contribute to DMPK as contributing authors or reviewers should be listed as specific contributions to DMPK.

III. Selection Rules and Bylaws for Fellows

The following are the rules and regulations for the selection of Fellows. Please refer to them at the time of application.

 

Selection Rules for JSSX Fellows

The Society shall establish the JSSX Fellow (hereinafter referred to as “JSSX Fellow”) system. As part of the Society’s social mission to contribute to drug development and medical care through research, education, and administration in the field of pharmacokinetics, and in light of the Society’s membership, which includes members from a wide range of industrial, academic, and governmental fields and from various backgrounds, as well as its active international activities, Fellows shall be selected from a wide range of national and international organizations. The title of Fellow is given to individuals who have made significant contributions to the society and are expected to continue to make contributions to the society. The title of Fellow is permanent.

Fellows shall be awarded once a year, in principle, to a small number of individuals.

Fellow recipients shall be selected in accordance with the Fellow Selection Regulations. The President shall receive a report from the Selection Committee on the results of the selection process in accordance with the bylaws, and shall consult with the Board of Directors to determine the recipients of Fellowships.

The awarding of Fellow titles shall take place at the General Assembly.

 

Selection Rules for JSSX Fellows

Fellows shall be selected from among members nominated by a current or former JSSX Director or Fellow. However, foreign nationals need not necessarily be members of the Society.

The Selection Committee (hereinafter referred to as the “Committee”) shall consist of five or more members elected by the Board of Directors. However, nominees and those who submit letters of recommendation shall not be eligible for membership on the Selection Committee.

The Chairperson of the Selection Committee shall be elected by a mutual vote of the Committee members.

The Chairperson of the Selection Committee shall preside over the proceedings of the Committee and report the results of the selection to the President. Upon receiving the report on the selection results, the Chairman shall consult with the Board of Directors to determine the recipients of the awards.